The biopharmaceutical industry has seen significant growth and transformation over the past few decades. As drug development has become more complex with advancing technologies, outsourcing certain functions has become increasingly common for biopharma companies of all sizes. Contract manufacturing organizations (CMOs) and contract research organizations (CROs) have played a pivotal role in supporting drug development efforts for both large pharma and small biotech companies.
